Adma Biologics (ADMA) EBIT (2011 - 2026)
Adma Biologics (ADMA) posted EBIT of $52.45 million for Q2 2026, up 22.5% from $42.8 million a year earlier but down 10.0% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) EBIT (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Adma Biologics was $224.48 million, up 44.2% year-over-year; for FY2025, it came in at $191.44 million, up 37.7% from FY2024.
- In prior years, Adma Biologics' EBIT was $138.98 million in FY2024 (+542.5%), $21.63 million in FY2023, -$39.37 million in FY2022 and -$58.37 million in FY2021.
- Quarterly EBIT has run from a low of -$14.82 million in Q1 2022 to a high of $62.75 million in Q4 2025 over five years.
- On a year-over-year basis, EBIT has increased in each of the last eight quarters, with growth averaging 97.1% over the last eight quarters.
- The year-over-year growth in EBIT has ranged between 9.2% (Q2 2025) and 356.4% (Q3 2024) over the last five years.
- According to Business Quant data, EBIT for the three prior quarters was $58.27 million (Q1 2026), $62.75 million (Q4 2025) and $51.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn | 52.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.45 Mn |
| Mar 31, 2026 | 58.27 Mn |
| Dec 31, 2025 | 62.75 Mn |
| Sep 30, 2025 | 51.01 Mn |
| Jun 30, 2025 | 42.80 Mn |
| Mar 31, 2025 | 34.88 Mn |
| Dec 31, 2024 | 38.32 Mn |
| Sep 30, 2024 | 39.64 Mn |
| Jun 30, 2024 | 39.20 Mn |
| Mar 31, 2024 | 21.82 Mn |
| Dec 31, 2023 | 14.23 Mn |
| Sep 30, 2023 | 8.69 Mn |
| Jun 30, 2023 | -473,000.00 |
| Mar 31, 2023 | -813,000.00 |
| Dec 31, 2022 | -6.06 Mn |
| Sep 30, 2022 | -9.32 Mn |
| Jun 30, 2022 | -9.17 Mn |
| Mar 31, 2022 | -14.82 Mn |
| Dec 31, 2021 | -13.19 Mn |
| Sep 30, 2021 | -14.44 Mn |
API Access
Adma Biologics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();